Shopping Cart 0
Cart Subtotal

MediPoint: Viscosupplementation-Europe Analysis and Market Forecasts

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 5000

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 10000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 15000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies


MediPoint: Viscosupplementation-Europe Analysis and Market Forecasts


Osteoarthritis (OA) constitutes a growing public health burden, and is the most common cause of musculoskeletal disability around the world. Resulting from a complex interaction of biomechanical, biochemical, and genetic factors, OA develops slowly and is characterized by the degradation of the affected joint's cartilage and bone hypertrophy. The disability is accompanied by joint pain, stiffness, and loss of range of motion. Initially treated with various therapies including physical therapy and nonsteroidal anti-inflammatory drugs (NSAIDs), advanced cases of OA have traditionally been treated surgically. However, intra-articular viscosupplementation with hyaluronic acid (HA), a high-molecular-weight glycosaminoglycan, has become an increasingly accepted therapeutic alternative to knee replacement surgery in the symptomatic management of OA over the past decade.

This report focuses on the market outlook for viscosupplementation products in Europe (Austria, Belgium, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Russia, Spain, Sweden, Switzerland, Turkey, and UK). The analysis discusses the major drivers and barriers of adoption, and provides an in-depth understanding of the future outlook for this market by segment and geography.

Key Questions Answered

What is the current and future viscosupplementation market outlook in the developed and emerging markets? What trends are affecting the European market?

Which are the key, high growth markets that viscosupplementation manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products in each segment?

What are the unmet needs with the current generation of viscosupplementation products? How will emerging technologies fulfill these unmet needs?

What clinical factors and technical specifications influence a physician to use one type of device over another? What is physician perception and market outlook for viscosupplementation?

What are the challenges and complications that have hindered widespread adoption?

With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the viscosupplementation market?


Overview of recent key industry events and analysis of their market impact.

Annualized total market revenue by type of device, procedure trends, and market outlooks by segment and by country through 2023.

Key topics covered include strategic competitor assessment, market characterization, and implications of the emerging technologies in the market.

Pipeline analysis: Comprehensive data split across different stages of development, including a discussion of emerging trends and devices in development.

Analysis of the current and future market competition in the European viscosupplementation market. Insightful review of the key industry drivers, barriers, and challenges. Each trend is independently researched to provide qualitative analysis of its implications.

Reasons to buy

The report will enable you to-

Develop and design your in-licensing and out-licensing strategies through a review of marketed products and technologies.

Develop business strategies by understanding the trends shaping and driving the viscosupplementation market.

Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the viscosupplementation market in the future.

Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.

Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

Track device sales in country-specific viscosupplementation markets from 2014-2023.

Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.


Table Of Content


Table of Contents

1 About the Authors 2

1.1 Analysts 2

1.1.1 Jennifer Ryan, Orthopedic Analyst, Medical Devices 2

1.1.2 Linda Tian, Managing Analyst, Medical Devices 2

1.1.3 Global Head of Medical Devices 2

2 Table of Contents 3

2.1 List of Tables 5

2.2 List of Figures 5

3 Executive Summary 6

3.1 Overview 6

3.2 Market Dynamics 7

3.3 Key Players in the Viscosupplementation Market 8

3.4 Viscosupplementation Market Future Outlook 8

4 Introduction 9

4.1 Catalyst 9

4.2 Related Reports 9

4.3 Upcoming Related Reports 10

5 Market Outlook 11

5.1 Procedure Trends 11

5.2 Pricing Trends 13

5.3 Revenue Trends 15

5.4 Company Share Analysis 17

6 Market Insights 18

6.1 Europe 18

6.1.1 Denmark, Finland, Norway, and Sweden 19

6.1.2 Belgium, France, and Netherlands 19

6.1.3 Germany and Switzerland 20

6.1.4 UK and Ireland 21

6.1.5 Italy, Portugal, and Spain 22

6.1.6 Austria, Czech Republic, Hungary, and Poland 22

6.1.7 Greece, Russia, and Turkey 22

7 Competitive Assessment 23

7.1 Overview 23

7.2 Anika Therapeutics 23

7.2.1 Overview 23

7.2.2 Portfolio Assessment 24

7.2.3 Competitive Positioning 24

7.3 Ferring Pharmaceuticals 24

7.3.1 Overview 24

7.3.2 Portfolio Assessment 25

7.3.3 Competitive Positioning 25

7.4 Fidia Farmaceutici 25

7.4.1 Overview 25

7.4.2 Portfolio Assessment 25

7.4.3 Competitive Positioning 26

7.5 Meda AB (Mylan) 27

7.5.1 Overview 27

7.5.2 Portfolio Assessment 27

7.5.3 News and Deals Analysis 27

7.5.4 Competitive Positioning 27

7.6 Sanofi 28

7.6.1 Overview 28

7.6.2 Portfolio Assessment 28

7.6.3 Competitive Positioning 28

7.7 Other Players 29

8 Appendix 31

8.1 Bibliography 31

8.2 Abbreviations 31

8.3 Methodology 32

8.3.1 Overview 32

8.3.2 Coverage 32

8.3.3 Secondary Research 32

8.3.4 Forecasting Methodology 33

8.3.5 Primary Research Summary 34

8.4 About MediPoint 35

8.5 About GlobalData 35

8.6 Contact Us 35

8.7 Disclaimer 36

List Of Figure

List of Figures

Figure 1: Viscosupplementation Sales for Europe, by Country, 2016 and 2023 7

List Of Table

List of Tables

Table 1: Key Metrics in the Europe Viscosupplementation Market 6

Table 2: Europe Viscosupplementation Volume Forecast, 2014-2023 11

Table 3: Europe Viscosupplementation Average Selling Price Forecast ($), 2014-2023 13

Table 4: Europe Viscosupplementation Market Revenue Forecast ($M), 2014-2023 15

Table 5: Europe Viscosupplementation Company Share Analysis, 2016 17

Table 6: Anika Therapeutics-Key Marketed Products Assessment 24

Table 7: Ferring Pharmaceuticals-Key Marketed Products Assessment 25

Table 8: Fidia Farmaceutici-Key Marketed Products Assessment 25

Table 9: Fidia Farmaceutici-Key Clinical Trials 26

Table 10: Meda AB-Key Marketed Products Assessment 27

Table 11: Sanofi-Key Marketed Products Assessment 28

Table 12: Summary of Other Players in the Viscosupplementation Market, 2017 29

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to

Products and Companies


Anika Therapeutics, Ferring Pharmaceuticals, Fidia Farmaceutici, Sanofi, Seikagaku Corporation